Home » Topics » BioWorld Science

BioWorld Science
RSS

MMP inhibitors from Otsuka

Oct. 11, 1996

DuPont Merck describes bisnaphthalimide anticancer drugs

Oct. 11, 1996

ProScript licenses rights to inhibitors of Ras processing

Oct. 11, 1996

Merck describes natural inhibitors of Ras farnesylation

Oct. 11, 1996

Farnesyltransferase inhibitors discovered by RPR

Oct. 11, 1996

Ovarian cancer vaccine enters phase II/III trials

Oct. 11, 1996

New company focuses on small molecules that mimic binding regions of Ig proteins

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Antineoplastic aromatase inhibitor from Yamanouchi shows potential for hormone-related illnesses

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...